Cited by 626Inflammatory Bowel DiseaseGastrointestinal motility and disordersOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Intestinal permeability and the prediction of relapse in Crohn's disease

Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., Lochs, H.·1993·The Lancet

Open this paper in CoChat — free account

Abstract

To see whether intestinal permeability (IP) predicted relapse in Crohn's disease, we measured IP in 72 patients with quiescent Crohn's disease using the lactulose-mannitol test. The permeability index (lactulose/mannitol) was significantly higher in patients than in controls (0.046 [SEM 0.005] vs 0.018 [SEM 0.002], respectively). Patients were followed for 1 year after the test. 26 of the 37 patients with raised permeability, but only 6 of the 35 with normal permeability relapsed within 1 year after the test (p < 0.001). The sensitivity of the permeability test as a predictor for relapse was 81%. A significant correlation was found between the value of the permeability index and the probability of relapse (p < 0.01). These results show that increases in intestinal permeability precede clinical relapses in Crohn's disease and so are an indicator of subclinical disease. The measurement of intestinal permeability may lead to a better understanding of the pathogenesis of Crohn's disease.

Integrity signals

Registry

Crossref · 10.1016/0140-6736(93)90882-h

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Applied logistic regression
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,516
Development of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
The Analysis of Binary Data.
Plackett, R. L., & Cox, D. R. (1971) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2344247 · Cited by 2,274
European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
Malchow, H. A., Ewe, K., Brandes, J. W., Goebell, H., Ehms, H., Sommer, H., & Jesdinsky, H. J. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90409-8 · Cited by 931
Evidence for continuous stimulation of interleukin-6 production in Crohn's disease
Groß, V., Andus, T., Caesar, I., Roth, M., & Schölmerich, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90098-j · Cited by 293
A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease
Brignola, C., Campieri, M., Bazzocchi, G., Farruggia, P., Tragnone, A., & Lanfranchi, G. A. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90206-4 · Cited by 159

Show all 16 references

Sorted by citations

Items 401–500 of 619

A spotlight on intestinal permeability and inflammatory bowel diseases
Räth, T., Atreya, R. N., & Neurath, M. F. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2242772 · Cited by 21
Effects of zinc deficiency on immune functions
Prasad, A. S. (2000) · The Journal of Trace Elements in Experimental Medicine · doi:10.1002/(sici)1520-670x(2000)13:1 · Cited by 87
Epithelial Cells
Edelblum, K. L., & Turner, J. R. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00012-4 · Cited by 20
Altered intestinal permeability is predictive of early relapse in children with steroid‐responsive ulcerative colitis
Miele, E., Pascarella, F., Quaglietta, L., Giannetti, E., Greco, L., Troncone, R., & Staiano, A. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03291.x · Cited by 20
Intestinal Permeability to Polyethylene Glycols in Monozygotic Twins with Crohn's Disease
Lindberg, E., Söderholm, J. D., Olaison, G., Tysk, C., & Järnerot, G. (1995) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529509096327 · Cited by 20
Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: Views over hidden possibilities
Shankar, E. M., Vignesh, R., Murugavel, K. G., Balakrishnan, P., Sekar, R., Lloyd, C., Solomon, S., & Kumarasamy, N. (2007) · AIDS Research and Therapy · doi:10.1186/1742-6405-4-29 · Cited by 20
Interconnected microbiomes—insights and innovations in female urogenital health
Al, K. F., Parris, J., Engelbrecht, K. C., Reid, G., & Burton, J. P. (2024) · FEBS Journal · doi:10.1111/febs.17235 · Cited by 19
Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche
Lim, R., Banerjee, A., Biswas, R., Chari, A. N., & Raghavan, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.966662 · Cited by 21
Increased prevalence of gout in patients with inflammatory bowel disease: A population‐based study
Hamid, O., Alchirazi, K. A., Eltelbany, A., Nanah, R., & Regueiro, M. D. (2023) · JGH Open · doi:10.1002/jgh3.12963 · Cited by 19
Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: A study in Crohn’s disease
Prager, M., Durmus, T., Büttner, J., Molnár, T., de Jong, D. J., Drenth, J. P. H., Baumgart, D. C., Sturm, A., Farkas, K., Witt, H., et al. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.928903 · Cited by 19
Microbiota transplantation reveals beneficial impact of berberine on hepatotoxicity by improving gut homeostasis
Qin, C., Zhang, H., Zhao, L., Zeng, M., Huang, W., Fu, G., Zhou, W., Wang, H., & Yan, H. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9202-0 · Cited by 19
Clinical relevance of measuring colonic permeability
Haas, V. K., Büning, C., Bühner, S., von Heymann, C., Valentini, L., & Lochs, H. H. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02075.x · Cited by 19
Self-citation
Phytochemicals as Modulators of PPARs and RXRs
Ko, J. K.-S., Lee, S. S., & Martin, H. (2010) · PPAR Research · doi:10.1155/2010/407650 · Cited by 20
Altered Prostasin (CAP1/Prss8) Expression Favors Inflammation and Tissue Remodeling in DSS-induced Colitis
Keppner, A., Malsure, S., Nobile, A., Auberson, M., Bonny, O., & Hümmler, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000940 · Cited by 19
Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease
Olbe, L. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701676971 · Cited by 17
CD4+ T cells from 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis rodents migrate to the recipient's colon upon transfer; down-regulation by CD8+ T cells
Palmen, M. J. H. J., Wijburg, O. L. C., Kunst, I. H., Kroes, H., & van Rees, E. P. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00564.x · Cited by 19
Fecal excretion of human deoxyribonucleic acid as an index of inflammatory activity in ulcerative colitis
Casellas, F., Antolı́n, M., Varela, E., Garcia-Lafuente, A. M., Guarner, F., Borruel, N., Miró, J. R. A., & Malagelada, J. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00291-5 · Cited by 18
Mechanisms and Treatment of Diarrhea in Inflammatory Bowel Diseases
Urayama, S., & Chang, E. B. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030207 · Cited by 18
Slipping the barrier: how variants in CARD15 could alter permeability of the intestinal wall and population health
Schreiber, S. (2006) · Gut · doi:10.1136/gut.2005.076075 · Cited by 18
Urinary Excretion of Iohexol as a Marker of Disease Activity in Patients with Inflammatory Bowel Disease
Halme, L., Edgren, J., Turpeinen, U., von Smitten, K., & Stenman, U. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709000185 · Cited by 17
Unfolded protein response transcription factor XBP1 suppresses necroptosis-induced colitis by reinforcing the mucus barrier
Kaya, G. G., Schwarzer, R., Dannappel, M., Vlantis, K., Göbel, U., Kondylis, V., Nedospasov, S. A., & Pasparakis, M. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.023 · Cited by 16
Protease inhibitory activity of secretory leukocyte protease inhibitor ameliorates murine experimental colitis by protecting the intestinal epithelial barrier
Ozaka, S., Sonoda, A., Ariki, S., Kamiyama, N., Hidano, S., Sachi, N., Ito, K., Kudo, Y., Minata, M., Saechue, B., et al. (2021) · Genes to Cells · doi:10.1111/gtc.12888 · Cited by 16
Genes involved in the regulation of intestinal permeability and their role in ulcerative colitis
Prager, M., Büttner, J., & Büning, C. (2015) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12296 · Cited by 16
Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?
Heuston, S., & Hyland, N. P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02055.x · Cited by 16
Alterations in Serum Anti-α-Galactosyl Antibodies in Patients with Crohn's Disease and Ulcerative Colitis
D’Alessandro, M., Mariani, P., Lomanto, D., Bachetoni, A., & Speranza, V. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5180 · Cited by 16
Estimation of intestinal permeability in healthy dogs using the contrast medium iohexol
Klenner, S., Coenen, M., Failing, K., Hewicker‐Trautwein, M., Ternes, W., Verspohl, J., & Spillmann, T. (2009) · Veterinary Clinical Pathology · doi:10.1111/j.1939-165x.2009.00136.x · Cited by 16
Bowel permeability is improved in Crohn's disease after ileocolectomy
Koltun, W. A., Tilberg, A. F., Page, M. J., & Poritz, L. S. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02236253 · Cited by 16
Intestinal permeability: the basics
Bjarnason, I., Macpherson, A. J., & Menzies, I. S. (1994) · Springer eBooks · doi:10.1007/978-94-009-0371-5_6 · Cited by 16
Dysregulation of γδ intraepithelial lymphocytes precedes Crohn’s disease–like ileitis
Xu, W., Golovchenko, N. B., Martínez-Vargas, I. U., Fong, A., Rout, P., Achi, S. C., Bucar, E. B., Hsieh, J. J., Vidmar, K. J., Zhang, L., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adk7429 · Cited by 15
Myosin light chain kinase regulates intestinal permeability of mucosal homeostasis in Crohn’s disease
Yao, Y., Feng, Q., & Shen, J. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1850269 · Cited by 15
Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model
Brice, D. P., Murray, G. I., Wilson, H. M., Porter, R. J., Berry, S., Durum, S. K., & McLean, M. H. (2022) · Biology · doi:10.3390/biology11030427 · Cited by 15
Recent advances in understanding and managing Crohn’s disease
Stange, E. F., & Wehkamp, J. (2016) · F1000Research · doi:10.12688/f1000research.9890.1 · Cited by 15
Effects of Anti-Cytokine Antibodies on Gut Barrier Function
Liu, F., Lee, S. A., Riordan, S. M., Zhang, L., & Zhu, L. (2019) · Mediators of Inflammation · doi:10.1155/2019/7028253 · Cited by 15
Construction of an ileocolic neosphincter — Nipple valve anastomosis for prevention of postoperative recurrence of Crohn's disease in the neoterminal ileum after ileocecal or ileocolic resection.
Bakkevold, K. E. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.04.002 · Cited by 15
Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study
Bours, M. J. L., Bos, H. J., Meddings, J. B., Brummer, R. J., van den Brandt, P. A., & Dagnelie, P. C. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-23 · Cited by 15
Barrier Function of the Gut and Multiple Organ Dysfunction after Cardiac Surgery
Braun, J.-P., Bühner, S., Kastrup, M., Dietz, E., Langer, K., Dohmen, P., Lochs, H. H., & Spies, C. (2007) · Journal of International Medical Research · doi:10.1177/147323000703500107 · Cited by 15
Self-citation
Antibiotic Use in Crohnʼs Disease
Prantera, C., Scribano, M. L., Berto, E., & Zannoni, F. (1997) · BioDrugs · doi:10.2165/00063030-199708040-00005 · Cited by 15
Glutamine: the link between depletion and diminished gut function?
Soeters, P. B. (1996) · Journal of the American College of Nutrition · doi:10.1080/07315724.1996.10718588 · Cited by 15
DICAM Attenuates Experimental Colitis via Stabilizing Junctional Complex in Mucosal Barrier
Han, S. W., Kim, J., Lho, Y., Cho, H. J., Jung, Y., Kim, J., Lee, H., Lee, Y., & Kim, E. S. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy373 · Cited by 14
Hypoxia-inducible factor hydroxylase inhibition enhances the protective effects of cyclosporine in colitis
Halligan, D. N., Khan, M. N., Brown, E., Rowan, C. R., Coulter, I. S., Doherty, G. A., Tambuwala, M. M., & Taylor, C. T. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00049.2019 · Cited by 14
Colonic hypersensitivity and low‐grade inflammation in a spontaneous animal model for functional gastrointestinal disorders
Méleine, M., Accarie, A., Wauters, L. I., Tóth, J. G., Gourcerol, G., Tack, J. F., Farré, R., & Vanuytsel, T. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13614 · Cited by 14
Review: Human Intestinal Barrier—Optimal Measurement and Effects of Diet in the Absence of Overt Inflammation or Ulceration
Camilleri, M. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70225 · Cited by 14
Current Trends in IBD—Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System
Yau, Y. Y., Wasinger, V. C., Hirten, R. P., Chuang, E., Huntsman, M., Stylli, J., Shimizu, J., Yajnik, V., Smith, J. A., Lee, S. N., et al. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab179 · Cited by 13
The N-Terminal Fragment of Chromogranin A, Vasostatin-1 Protects Mice From Acute or Chronic Colitis Upon Oral Administration
Rumio, C., Dusio, G. F., Colombo, B., Gasparri, A. M., Cardani, D., Marcucci, F., & Corti, A. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2031-9 · Cited by 13
Interactions among Interleukin-6, C-Reactive Protein and Interleukin-6 (-174) G/C Polymorphism in the Pathogenesis of Crohn’s Disease and Ulcerative Colitis
Takač, B. (2020) · Acta Clinica Croatica · doi:10.20471/acc.2020.59.01.09 · Cited by 13
The hygiene hypothesis and affective and anxiety disorders
Rook, G. A. W., & Lowry, C. A. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_11 · Cited by 13
Nipple Valve Anastomosis for Preventing Recurrence of Crohn Disease in the Neoterminal Ileum after Ileocolic Resection: A Prospective Pilot Study
Bakkevold, K. E. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750024173 · Cited by 13
The Role of Antibiotics in Crohn’s Disease
Cangemi, J. R. (1999) · Digestive Diseases · doi:10.1159/000016897 · Cited by 13
Propionibacterium freudenreichii CIRM-BIA 129 mitigates colitis through S layer protein B-dependent epithelial strengthening
Mantel, M., Durand, T., Bessard, A., Pernet, S., Beaudeau, J., Laguna, J. G., Maillard, M.-B., Guédon, É., Neunlist, M., Loir, Y. L., et al. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00198.2023 · Cited by 12
A Promoter Variant Within the Aryl Hydrocarbon Receptor Gene Is Associated with an Epithelial Barrier Defect in Smokers with Crohnʼs Disease
Prager, M., Büttner, J., Grunert, P., Ellinghaus, D., & Büning, C. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000910 · Cited by 12
Do changes in intestinal permeability predict disease relapse in Crohnʼs disease?
Vogelsang, H. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20617 · Cited by 12
Self-citation
Differential Immunohistochemical Expression of Syndecan-1 and Tumor Necrosis Factor Alpha in Colonic Mucosa of Patients with Crohn’s Disease
Principi, M., Day, R. M., Marangi, S., Burattini, O., Francesco, V. D., Ingrosso, M., Pisani, A. R., Panella, C., Forbes, A., Leo, A. D., et al. (2006) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923970600815048a · Cited by 12
Association between intestinal tight junction permeability and whole-body electrical resistance in healthy individuals: A hypothesis
Valentini, L., Eggers, J., Ockenga, J., Haas, V. K., Bühner, S., Winklhofer‐Roob, B. M., Hengstermann, S., Sinn, B., Weigel, A., Norman, K., et al. (2009) · Nutrition · doi:10.1016/j.nut.2008.11.033 · Cited by 11
Self-citation
MicroRNA23a Overexpression in Crohn’s Disease Targets Tumour Necrosis Factor Alpha Inhibitor Protein 3, Increasing Sensitivity to TNF and Modifying the Epithelial Barrier
Felwick, R., Dingley, G., Martínez-Nuñez, R. T., Sánchez-Elsner, T., Cummings, F. J. R., & Collins, J. E. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz145 · Cited by 11
Structural and functional intestinal barrier abnormalities and chronic kidney disease. Literature review. Part I
Pyatchenkov, M. O., Markov, A. G., & Rumyantsev, A. S. (2022) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2022-26-1-10-26 · Cited by 11
Profound haemodilution during normothermic cardiopulmonary bypass influences neither gastrointestinal permeability nor cytokine release in coronary artery bypass graft surgery
Berger, K., Sander, M., Spies, C., Weymann, L., Bühner, S., Lochs, H. H., Wernecke, K. ‐., & von Heymann, C. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep201 · Cited by 11
Self-citation
NMR‐based urinary profiling of lactulose/mannitol ratio used to assess the altered intestinal permeability in acute on chronic liver failure (ACLF) patients
Kumar, D., Pandey, G., Bansal, D., Rawat, A. K., Kumar, U., Dubey, D., Guleria, A., & Saraswat, V. A. (2016) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.4525 · Cited by 11
Increased leukocyte adhesiveness/ aggregation in patients with inflammatory bowel disease during remission
Arber, N., Hallak, A., Dotan, I., Bujanover, Y., Liberman, E., Santo, M., Moshkowitz, M., Tiomny, E., Aronson, M., Berliner, S., et al. (1996) · Diseases of the Colon & Rectum · doi:10.1007/bf02056941 · Cited by 11
Inflammatory Bowel Diseases and Enteric Microbiota
Kim, J. M. (2010) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2010.55.1.4 · Cited by 11
Astragaloside IV: A Promising Drug to Prevent the Transition from Colitis to Colorectal Cancer
Ran, J., Ai, Y., Ni, J., Zhang, Y., Chen, J., Wang, T., Ma, J., Zheng, J., Li, R., Ma, X., et al. (2025) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x25500405 · Cited by 10
The ClC-2 Chloride Channel Activator, Lubiprostone, Improves Intestinal Barrier Function in Biopsies from Crohn’s Disease but Not Ulcerative Colitis Patients
Park, Y. S., Kang, S., Marchelletta, R. R., Penrose, H. M., Ruiter-Visser, R., Jung, B., Docherty, M. J., Boland, B. S., Sandborn, W. J., & McCole, D. F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030811 · Cited by 10
Endothelial and Epithelial Barriers in Graft-Versus-Host Disease
Nalle, S. C., & Turner, J. R. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4711-5_5 · Cited by 10
No Static at All
Graham, W. V., Marchiando, A. M., Shen, L., & Turner, J. R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04050.x · Cited by 10
The Pathogenesis, Clinical Implications, and Treatment of Intestinal Hyperpermeability
Miller, A. L. (1997) · Cited by 10
Epithelial NELF guards intestinal barrier function to ameliorate colitis by maintaining junctional integrity
Ou, J., Guan, X., Wang, J., Wang, T., Zhang, B., Li, R., Xu, H., Hu, X., & Guo, X.-K. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00465-9 · Cited by 10
Apical junction complex proteins and ulcerative colitis: a focus on the PTPRS gene
Muise, A. M., & Rotin, D. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.4.465 · Cited by 10
Standardization of the Lactulose-Mannitol Test in Rats: Application to Burn Injury
Pernet, P., Aussel, C., Boucher, J. L., GIBOUDEAU, J., Cynober, L., & Coudray‐Lucas, C. (1998) · European Surgical Research · doi:10.1159/000008560 · Cited by 10
Interplay between Multisystem Inflammatory Syndrome in Children, Interleukin 6, Microbiome, and Gut Barrier Integrity
Zari, A., Redwan, E. M. M. M., Raszek, M., Cowley, D., Hromić‐Jahjefendić, A., Uversky, V. N., Fabrowski, M., Brogna, C., Piscopo, M., & Rubio‐Casillas, A. (2024) · Immuno · doi:10.3390/immuno4030015 · Cited by 9
Highly Sensitive, Flow Cytometry-Based Measurement of Intestinal Permeability in Models of Experimental Colitis
Tsai, K., Ma, C., Han, X., Allaire, J. M., Lunken, G., Crowley, S. M., Yu, H., Jacobson, K., Xia, L., Priatel, J. J., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.004 · Cited by 9
La barrera intestinal: trastornos funcionales en enfermedades digestivas y extradigestivas
Pascual, S., Navarro-Martínez, J., & Pérez‐Mateo, M. (2001) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(01)70167-7 · Cited by 9
Intestinal Permeability Measurements — A New Application for Water-Soluble Contrast Media?
Andersen, R., & Lærum, F. (1995) · Acta Radiologica · doi:10.1177/0284185195036s39930 · Cited by 9
Intestinal Permeability In Vivo in Patients With Inflammatory Bowel Disease: Comparison of Active Disease and Remission
Dunleavy, K. A., Rypstra, C. R., Busciglio, I. A., Eckert, D. J., Ryks, M. D., Omerdic, E., Chedid, V. G., Raffals, L. E., & Camilleri, M. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf043 · Cited by 8
The effects of STAT1 dysfunction on the gut
Thoeni, C. E., Hamilton, E. A., Elkadri, A. A., Murchie, R., Fiedler, K. B., Ovadia, A., Sharfe, N., Ngan, B., Cutz, E., Nahum, A., et al. (2015) · LymphoSign Journal · doi:10.14785/lpsn-2015-0012 · Cited by 8
Intestinal tight junctions and their importance in health and disease: role of dietary lipids
Wild, G., Madsen, K. L., & Thomson, A. B. R. (1997) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(96)00151-9 · Cited by 8
The X-Ray Contrast Medium Iodixanol Detects Increased Colonic Permeability Equally Well as51Cr-labeled Ethylenediaminetetraacetic Acid in Experimental Colitis of Rats
Andersen, R., Hosaka, J., Halstensen, T. S., Stordahl, A., Tverdal, A., Aabakken, L., & Lærum, F. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609031978 · Cited by 8
Unlocking the Gates to Inflammatory Bowel Disease: The Role of Enterococcus faecalis Gelatinase
Vedantam, G., & Viswanathan, V. K. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.022 · Cited by 8
Serum biomarkers of intestinal barrier dysfunction predict postoperative endoscopic recurrence in Crohn’s disease patients
Tan, L., Li, Y., Ding, C., Qian, J., & Cui, X. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04273-4 · Cited by 7
Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitis
Räth, T., Atreya, R. N., Bodenschatz, J., Uter, W. J. C., Geppert, C. I., Vitali, F., Zundler, S., Waldner, M. J., Hartmann, A., & Neurath, M. F. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1221449 · Cited by 7
Finding a mate for MLCK: improving the potential for therapeutic targeting of gut permeability
McCole, D. F. (2022) · Gut · doi:10.1136/gutjnl-2022-327599 · Cited by 7
Usefulness of an elemental diet in Crohn’s disease
Takahashi, H., Ando, T., Watanabe, O., Maeda, O., Ishiguro, K., Ohmiya, N., Niwa, Y., & Goto, H. (2007) · Inflammopharmacology · doi:10.1007/s10787-006-1570-0 · Cited by 7
Systematic review on drug and diet-induced endoscopic remission in Crohnʼs disease
Pimentel‐Nunes, P., Dinis-Ribeiro, M. J., & Magro, F. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283196b03 · Cited by 7
Use of Prebiotics for Inflammatory Bowel Disease
Szilagyi, A. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/415698 · Cited by 7
Assessment of the Intestinal Permeability following Postoperative Chemotherapy for Human Malignant Disease
Inutsuka, S., Takesue, F., Yasuda, M., Honda, M., Nagahama, S., Kusumoto, H., Nozoe, T., & Korenaga, D. (2003) · European Surgical Research · doi:10.1159/000067037 · Cited by 7
What caused the increase of autoimmune and allergic diseases: A decreased or an increased exposure to luminal microbial components?
Qin, X. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i8.1306 · Cited by 7
Iohexol-based measurement of intestinal permeability in birds
Wilhelm, F. R., Krautwald‐Junghanns, M., Ortín-Piqueras, V., Junnila, J. J. T., Cramer, K., Forsgård, R. A., Frías, R., Spillmann, T., & Schmidt, V. (2020) · Journal of Exotic Pet Medicine · doi:10.1053/j.jepm.2020.04.004 · Cited by 7
Effects of Intestinal Surgery on Pulmonary, Glomerular, and Intestinal Permeability, and its Relation to the Hemodynamics and Oxidative Stress
Matějovič, M., Kroužecký, A., Rokyta, R., Třeška, V., Spidlen, V., & Novák, I. (2004) · Surgery Today · doi:10.1007/s00595-003-2642-z · Cited by 7
Photopheresis Treatment in Severe Crohn Disease
Guariso, G., Renata D'Incà, Sturniolo, G., Zancan, L., & Dall’Amico, R. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2003.tb12049.x · Cited by 7
NAFLD Is Associated With Quiescent Rather Than Active Crohn’s Disease
Mchenry, S. A., Glover, M. T., Ahmed, A. S., Alayo, Q. A., Zulfiqar, M., Ludwig, D. R., Ciorba, M. A., Davidson, N. O., & Deepak, P. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad129 · Cited by 6
Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome
Büttner, J., Blüthner, E., Greif, S., Kühl, A. A., Elezkurtaj, S., Ulrich, J., Maasberg, S., Jochum, C., Tacke, F., & Pape, U. (2023) · Nutrients · doi:10.3390/nu15194220 · Cited by 6
Isolation of Myenteric and Submucosal Plexus from Mouse Gastrointestinal Tract and Subsequent Co-Culture with Small Intestinal Organoids
Llorente, C. (2024) · Cells · doi:10.3390/cells13100815 · Cited by 6
Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn’s disease patients
Greuter, T., Franc, Y., Kaelin, M., Schoepfer, A. M., Schreiner, P., Zeitz, J., Scharl, M. M., Misselwitz, B., Straumann, A., Vavricka, S. R., et al. (2018) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x18757715 · Cited by 6
The epithelium takes the stage in asthma and inflammatory bowel diseases
López-Posadas, R., Bagley, D., Pardo-Pastor, C., & Zapater, E. O. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1258859 · Cited by 5
Chromatographic Determination of Sugar Probes Used for Gastrointestinal Permeability Test by Employing Nickel‐Copper Nanoalloy Embedded in Carbon Film Electrodes
Shiba, S., Maruyama, R., Kamata, T., Kato, D., & Niwa, O. (2018) · Electroanalysis · doi:10.1002/elan.201800072 · Cited by 6
Enfermedad inflamatoria intestinal
Galland, L. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50049-x · Cited by 6
Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy
Stanković, B., Dragašević, S., Klaassen, K., Kotur, N., Dražilov, S. S., Zukić, B., Milutinovic, A. S., Alempijevic, T. M., Lukić, S., Popović, D., et al. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152945 · Cited by 6
Effect of a prebiotic‐enriched phytocompound in improving ovalbumin allergenicity
Metugriachuk, Y., TSUCHIYA, J., Marotta, F., KAWAKITA, S., OKURA, R., KUROI, O., & Minelli, E. (2006) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2006.00267.x · Cited by 6
Non-invasive investigation in patients with inflammatory joint disease
Pont, E. D., Renata D'Incà, Caruso, A., & Sturniolo, G. C. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2463 · Cited by 6
Epithelia and Gastrointestinal Function
Turner, J. R. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch18 · Cited by 6
Non-invasive fluorescence sensing reveals changes in intestinal barrier function and gastric emptying rate in a first-in-human study of Crohn’s disease
Gan, J., Chen, Q., Sánchez, E. M., Mandal, N., Xu, J., Wang, Z., Agarwal, A., Oluwatunmise, E., Ramkumar, P., Salam, A., et al. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251361634 · Cited by 5
Mechanism-based Drug Therapy of Inflammatory Bowel Disease With Special Reference to Rheumatic Disease
Park, J. J. (2020) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2020.27.3.128 · Cited by 5

Authors: Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H.
Corresponding author: Lochs, H.
ORCID: Waldhoer, T.
Venue: The Lancet
Publisher: Elsevier BV
Published: 1993-06
Volume: 341
Issue: 8858
Pages: 1437-1439
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/0140-6736(93)90882-h
OpenAlex: W2080195364
Cited by: 626
References: 16
Citations by year: 2026: 6 · 2025: 19 · 2024: 12 · 2023: 15 · 2022: 25 · 2021: 25 · 2020: 21 · 2019: 17 · 2018: 19 · 2017: 22 · 2016: 23 · 2015: 23 · 2014: 24 · 2013: 17 · 2012: 26
FWCI: 4.21
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords: Crohn's disease, intestinal permeability, recurrence prediction, lactulose/mannitol test, permeability index, subclinical disease, pathogenesis, inflammatory bowel disease
MeSH terms: Adult, Crohn Disease, Female, Humans, Intestinal Mucosa, Lactulose, Male, Mannitol, Permeability, Predictive Value of Tests, Recurrence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intestinal permeability and the prediction of relapse in Crohn's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks